Actual Medicinal Product (AMP) Allopurinol 300mg tablets (Crescent Pharma Ltd)
Stability Information
(Some stability information inherited from generic)
- Stability
-
Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Manufacturer recommends storing in original container. Protect from light. Anecdotal reports of use in MCAs (low quality evidence).
- Provenance
-
This recommendation is based on the products Zyloric 300mg tablets (Aspen) and Allopurinol 300mg (Ipca Laboratories Ltd) and Allopurinol 200mg tablets (Aspire Pharma).
- Generic
- Allopurinol
- Formulation
- Allopurinol 300mg tablets
-
Allopurinol
-
Allopurinol 300mg tablets
-
Allopurinol 300mg tablets (Crescent Pharma Ltd)
-
-